Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Brullo

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Medicinal Chemistry|June 25, 2021
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitorsChiara Brullo, Federica Rapetti, Sara Abbate, et al.
European Journal of Medicinal Chemistry|March 18, 2008
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidinesSilvia Schenone, Chiara Brullo, Olga Bruno, et al.
Bioorganic & Medicinal Chemistry|April 14, 2009
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitorsOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.
Molecules (Basel, Switzerland)|May 25, 2024
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole DerivativesFederica Rapetti, Andrea Spallarossa, Eleonora Russo, et al.
Bioorganic & Medicinal Chemistry|May 5, 2015
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitorsChiara Brullo, Matteo Massa, Carla Villa, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 25, 2018
Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis AgentsElda Meta, Chiara Brullo, Michele Tonelli, et al.
International Journal of Molecular Sciences|June 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma CellsErika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Organic & Biomolecular Chemistry|March 11, 2011
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivityTiziano Tuccinardi, Alessandra Tania Zizzari, Chiara Brullo, et al.
Journal of Medicinal Chemistry|March 19, 2004
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cellsFabio Carraro, Annalisa Pucci, Antonella Naldini, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Medicinal Chemistry|June 25, 2021
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitorsChiara Brullo, Federica Rapetti, Sara Abbate, et al.
European Journal of Medicinal Chemistry|March 18, 2008
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidinesSilvia Schenone, Chiara Brullo, Olga Bruno, et al.
Bioorganic & Medicinal Chemistry|April 14, 2009
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitorsOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.
Molecules (Basel, Switzerland)|May 25, 2024
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole DerivativesFederica Rapetti, Andrea Spallarossa, Eleonora Russo, et al.
Bioorganic & Medicinal Chemistry|May 5, 2015
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitorsChiara Brullo, Matteo Massa, Carla Villa, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 25, 2018
Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis AgentsElda Meta, Chiara Brullo, Michele Tonelli, et al.
International Journal of Molecular Sciences|June 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma CellsErika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Organic & Biomolecular Chemistry|March 11, 2011
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivityTiziano Tuccinardi, Alessandra Tania Zizzari, Chiara Brullo, et al.
Journal of Medicinal Chemistry|March 19, 2004
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cellsFabio Carraro, Annalisa Pucci, Antonella Naldini, et al.
Pageof 11